Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Lone Star State News.
Press releases published on April 2, 2025
Asia Pacific Wire & Cable Corporation Limited Announces Full Year 2024 Financial Results and Filing of Annual Report on Form 20-F for 2024
GlobeNewswire
·
April 2, 2025
TAIPEI, Taiwan, April 02, 2025 (GLOBE NEWSWIRE) -- Asia Pacific Wire …
Terrata Homes Opens First Community in Nashville
GlobeNewswire
·
April 2, 2025
WHITE HOUSE, Tenn., April 02, 2025 (GLOBE NEWSWIRE) -- LGI Homes, Inc. (NASDAQ: LGIH) announced the grand opening of its first Terrata Homes branded community in the Nashville market, Springbrook Reserve. This neighborhood in White House, Tennessee, offers …
Westwood Announces Monthly Income Distributions for Westwood Salient Enhanced Midstream Income ETF (MDST) and Westwood Salient Enhanced Energy Income ETF (WEEI)
GlobeNewswire
·
April 2, 2025
DALLAS, April 02, 2025 (GLOBE NEWSWIRE) -- Westwood Holdings Group (WHG), a publicly-traded investment management boutique and wealth management firm, today announced monthly income distributions for Westwood Salient Enhanced Midstream Income ETF (NYSE: …
Lexicon Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 2, 2025
THE WOODLANDS, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a presentation at the 24th Annual Needham Virtual Healthcare Conference 2025 on Wednesday, …
Prairie Operating Co. Announces 11-Well Development at Rusch Pad
GlobeNewswire
·
April 2, 2025
HOUSTON, TX, April 02, 2025 (GLOBE NEWSWIRE) -- Prairie Operating Co. (Nasdaq: PROP) (the “Company” or “Prairie”), today announced the launch of an 11-well development program at the Rusch Pad in Weld County, Colorado. The first well was spud on April 1, …
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
GlobeNewswire
·
April 2, 2025
STAFFORD, Texas, April 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …